Prosecution Insights
Last updated: November 20, 2026

Prema Maria Mertz, USPTO Patent Examiner

Listed by the USPTO as MERTZ, PREMA MARIA

Tech Center 1600 • Art Units: 1643 1646 1674

This examiner grants 72% of resolved cases

Analysis

MERTZ, PREMA MARIA has 774 resolved cases in Tech Center 1600 and Art Unit 1643. The allowance rate is 71.8%, and the median time to allowance is 1016 days. The record provides a substantial basis for setting prosecution expectations in the unit.

The interview lift is 34.6%, indicating a positive association between interviews and allowance outcomes. The listed companies are Pandion Operations Inc., Peptinov, and Dana-Farber Cancer Institute Inc. The listed firms are FisherBroyles, LLP, WOLF GREENFIELD & SACKS, P.C., and BakerHostetler.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

71.8%
Allow Rate
+11.8% vs TC avg
798
Total Applications
+34.6%
Interview Lift
1016
Avg Prosecution Days
Based on 774 resolved cases, 2023–2026

Rejection Statute Breakdown

6.8%
§101 Eligibility
13.0%
§102 Novelty
23.7%
§103 Obviousness
45.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17241935 DRUG DELIVERY COMPOSITIONS AND USES THEREOF Non-Final OA Dana-Farber Cancer Institute, Inc.
18436088 TREATMENT OF FIBROSIS Non-Final OA National University of Singapore
18033464 ANTIBODIES FOR USE IN THE DETECTION AND TREATMENT OF HEART DISEASE Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17755787 METHODS FOR TREATING DISEASES Final Rejection CHILDREN'S HOSPITAL MEDICAL CENTER
18253017 TREATMENT OF CASTLEMAN DISEASE Final Rejection THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
18565700 INTERFERONS AND NUCLEAR EXPORT INHIBITORS FOR USE IN METHODS OF TREATING CANCER Non-Final OA St. Jude Children's Research Hospital, Inc.
18576630 MUTANT IL-15 COMPOSITIONS AND METHODS THEREOF Non-Final OA Legend Biotech USA Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Prema Maria Mertz's allowance rate?

71.8% of resolved applications examined by Prema Maria Mertz were allowed (774 resolved cases), compared with 41.5% across Art Unit 1643 over the last five years.

Does an interview help with examiner Prema Maria Mertz?

This examiner's interview lift is +34.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Prema Maria Mertz take to allow a patent?

Applications allowed by Prema Maria Mertz took 1,016 days on average from filing to allowance.

Which art unit does examiner Prema Maria Mertz work in?

Prema Maria Mertz examines applications in Art Unit 1643 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month